Skip to content

Clinical trials

Completed Hepatitis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Status: Completed Country / region: South Korea Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20091
20122
20133
20151
20162
20173
20181
20202
20213
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences5
Vir Biotechnology, Inc.5
Boryung Pharmaceutical Co., Ltd3
GlaxoSmithKline3
Arbutus Biopharma Corporation1
Brii Biosciences Limited1
F-star Therapeutics, Inc.1
Human Genome Sciences Inc.1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis23
Hepatitis B13
Hepatitis B, Chronic11
Hepatitis, Chronic3
Hepatitis C2
Bronchiolitis Obliterans Syndrome1
Fibrosis1
Hepatitis A1
Hepatitis C, Chronic1
Liver Diseases1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.